ATNF logo

180 Life Sciences (ATNF) Company Overview

Profile

Full Name:

180 Life Sciences Corp.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 27, 2017

Indexes:

Not included

Website:

http://180lifesciences.com

Description:

ATNF, also known as 180 Life Sciences, focuses on developing innovative therapies for chronic pain and inflammation. The company uses advanced research to create treatments that improve patients' quality of life, aiming to address unmet medical needs in various health conditions.

Key Details

Price

$1.17

Market Cap

$2.31 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$52.59(+86.42% YoY)

PE Ratio

-

Annual ROE

15.61 K%

Annual Debt To Equity

-8.25

Beta

1.78

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Apr 7, 2020
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 28, 2024

Analyst ratings

Recent major analysts updates

May 9, 22 Maxim Group
Hold
Sep 15, 21 Maxim Group
Buy

Screeners with ATNF included

Growing Shares Outstanding
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Healthcare sector
All stocks
NASDAQ Listed Companies
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.17
ATNF price is $1.17

Price All-time High

$4552.40
ATNF price is currently -99.97% below its historical high of $4552.40

Price Analysts Target

-
ATNF price consensus analysts' forecast is unknown

Price Most Recent Change

-2.5%
ATNF price was down -2.5% on Mar 8, 2025

Price YTD Change

-37.77%
ATNF price is down -37.77% since January 1st

Price 3-Year Change

-99.89%
ATNF price is down -99.89% over the past 3 years

Market cap

Market Cap

$2.31 M
ATNF market capitalization is $2.31 million

Market Cap 3-Year Change

-97.67%
ATNF market capitalization is down -97.67% over the past 3 years

Market Cap All-time High

$366.01 M
ATNF market capitalization is currently -99.37% below its historical high of $366.01 million

Market Cap Sector Rank

7.16%
ATNF market capitalization is higher than 7.16% of companies in Healthcare sector

Technical

Beta

1.78
ATNF beta is 1.78

200-day SMA

$2.00
ATNF price is currently -41.59% below its 200-day simple moving average

14-day RSI

38.92
ATNF 14-day relative strength index is 38.92

30-day Relative Volume

0.27
ATNF 30-day relative volume is 0.27

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
ATNF annual revenue value is unknown

Annual Revenue Analysts Estimate

$16.61 M
ATNF annual revenue is currently equal to the consensus analysts' forecast

Annual Revenue 1-Year Change

-
ATNF annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
ATNF annual revenue is unknown

Profit

Annual Gross Profit

-
ATNF annual gross profit value is unknown

Annual Gross Margin

-
ATNF annual gross profit margin value is unknown

Annual Operating Profit

-$13.48 M
ATNF annual operating income is -$13.48 million

Annual Operating Margin

-
ATNF annual operating profit margin value is unknown

Annual Net Income

-$19.94 M
ATNF annual net profit is -$19.94 million

Annual Net Margin

-
ATNF annual net profit margin value is unknown

EPS

Annual EPS

-$52.59
ATNF annual earnings per share is -$52.59

Annual EPS Analysts Estimate

-
ATNF annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+86.42%
ATNF annual earnings per share is up +86.42% year-on-year

Annual EPS Sector Rank

5.75%
ATNF annual earnings per share is higher than 5.75% of companies in Healthcare sector

ROA & ROE

Annual ROA

-379.03%
ATNF annual return on assets is -379.03%

Annual ROE

15.61 K%
ATNF annual return on equity is 15.61 thousand%

EBIT & EBITDA

Annual EBIT

-$22.24 M
ATNF annual earnings before interest & taxes is -$22.24 million

Annual EBITDA

-$22.13 M
ATNF annual EBITDA is -$22.13 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ATNF price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ATNF price to earnings ratio is unknown

PB Ratio

PB Ratio

0.62
ATNF price to book ratio is 0.62

PB Ratio Sector Rank

31.71%
ATNF price to book ratio is higher than 31.71% of companies in Healthcare sector

PS Ratio

PS Ratio

-
ATNF price to sales ratio value is unknown

PS Ratio Sector Rank

-
ATNF price to sales ratio is unknown

Enterprise value

Enterprise Value

$5.37 M
ATNF enterprise value is $5.37 million

Enterprise Value Sector Rank

19%
ATNF enterprise value is higher than 19% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.80
ATNF EV/EBITDA is -1.80

EV/EBITDA Sector Rank

37.04%
ATNF EV/EBITDA is higher than 37.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.72
ATNF annual current ratio is 0.72

Annual Quick Ratio

-
ATNF annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-8.25
ATNF annual debt to equity ratio is -8.25

Annual Interest Coverage Ratio

-496.42
ATNF annual interest coverage ratio is -496.42

Risk & Stability

Piotroski F-Score

-
ATNF piotroski f-score value is unknown

Altman Z-Score

-
ATNF altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$5.26 M
ATNF annual total assets is $5.26 million

Annual Non Current Assets

$1.62 M
ATNF annual long term assets is $1.62 million

Annual Current Assets

$3.64 M
ATNF annual total current assets is $3.64 million

Annual Cash & Cash Equivalents

$1.98 M
ATNF annual cash & cash equivalents is $1.98 million

Equity

Annual Book Value

-$127.70 K
ATNF annual book value is -$127.70 thousand

Annual Working Capital

-$1.42 M
ATNF annual working capital is -$1.42 million

Liabilities

Annual Total Liabilities

$5.39 M
ATNF annual total liabilities is $5.39 million

Annual Total Long Term Liabilities

$324.60 K
ATNF annual total long term liabilities is $324.60 thousand

Annual Current Liabilities

$5.06 M
ATNF annual total current liabilities is $5.06 million

Annual Accounts Payable

$1.89 M
ATNF annual accounts payable is $1.89 million

Debt

Annual Total Debt

$1.05 M
ATNF annual total debt is $1.05 million

Annual Total Debt 1-Year Change

-21.33%
ATNF annual total debt is down -21.33% year-on-year

Annual Long Term Debt

$19.90 K
ATNF annual long term debt is $19.90 thousand

Annual Short Term Debt

$1.03 M
ATNF annual short term debt is $1.03 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$13.48 M
ATNF annual total expenses is $13.48 million

Annual Operating Expenses

$13.48 M
ATNF annual total operating expenses is $13.48 million

Annual Cost Of Goods Sold

-
ATNF annual cost of goods sold value is unknown

Annual SGA

$10.69 M
ATNF annual SGA is $10.69 million

Annual D&A

$105.70 K
ATNF annual depreciation & amortization is $105.70 thousand

Annual Interest Expense

$44.80 K
ATNF annual interest expense is $44.80 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$10.92 M
ATNF annual cash flow from operations is -$10.92 million

Annual CFO 1-Year Change

+9.94%
ATNF annual cash flow from operations is up +9.94% year-on-year

Annual CFI

-
ATNF annual cash flow from investing activities value is unknown

Annual CFI 1-Year Change

-
ATNF annual cash flow from investing activities 1-year change is unknown

Annual CFF

$5.91 M
ATNF annual cash flow from financing activities is $5.91 million

Annual CFF 1-Year Change

-45.67%
ATNF annual cash flow from financing activities is down -45.67% year-on-year

Free CashFlow

Annual FCF

-$10.92 M
ATNF annual free cash flow is -$10.92 million

Annual FCF 1-Year Change

+9.94%
ATNF annual free cash flow is up +9.94% year-on-year

CAPEX

Annual CAPEX

-
ATNF annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
ATNF annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

YCBD logo
cbdMD (YCBD)
TIVC logo
Tivic Health Systems (TIVC)
QLGN logo
Qualigen Therapeutics (QLGN)
SQL logo
SeqLL (SQL)
THAR logo
Tharimmune (THAR)
ELAB logo
Elevai Labs (ELAB)
VIRX logo
Viracta Therapeutics (VIRX)
SXTP logo
60 Degrees Pharmaceuticals (SXTP)
HCTI logo
Healthcare Triangle (HCTI)

FAQ

  • What is the ticker symbol for 180 Life Sciences?
  • Does 180 Life Sciences pay dividends?
  • What sector is 180 Life Sciences in?
  • What industry is 180 Life Sciences in?
  • What country is 180 Life Sciences based in?
  • When did 180 Life Sciences go public?
  • Is 180 Life Sciences in the S&P 500?
  • Is 180 Life Sciences in the NASDAQ 100?
  • Is 180 Life Sciences in the Dow Jones?
  • When was 180 Life Sciences's last earnings report?
  • When does 180 Life Sciences report earnings?
  • Should I buy 180 Life Sciences stock now?

What is the ticker symbol for 180 Life Sciences?

The ticker symbol for 180 Life Sciences is NASDAQ:ATNF

Does 180 Life Sciences pay dividends?

No, 180 Life Sciences does not pay dividends

What sector is 180 Life Sciences in?

180 Life Sciences is in the Healthcare sector

What industry is 180 Life Sciences in?

180 Life Sciences is in the Biotechnology industry

What country is 180 Life Sciences based in?

180 Life Sciences is headquartered in United States

When did 180 Life Sciences go public?

180 Life Sciences's initial public offering (IPO) was on June 27, 2017

Is 180 Life Sciences in the S&P 500?

No, 180 Life Sciences is not included in the S&P 500 index

Is 180 Life Sciences in the NASDAQ 100?

No, 180 Life Sciences is not included in the NASDAQ 100 index

Is 180 Life Sciences in the Dow Jones?

No, 180 Life Sciences is not included in the Dow Jones index

When was 180 Life Sciences's last earnings report?

180 Life Sciences's most recent earnings report was on Nov 14, 2024

When does 180 Life Sciences report earnings?

The next expected earnings date for 180 Life Sciences is May 15, 2025

Should I buy 180 Life Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions